Diethylene glycol (DEG) residue monitoring and detection is a critical quality control process that protects pharmaceuticals, cosmetics, and food products from a highly toxic contaminant with a documented history of fatal poisoning incidents. Regulatory authorities worldwide, including the FDA, WHO, and major pharmacopeias, now mandate rigorous DEG testing of glycerin, propylene glycol, and finished oral liquid products. This technical guide explains the principles, regulatory limits, analytical methods, and applications of DEG residue testing to support compliant and safe product manufacturing.
Technical Overview
Diethylene glycol (DEG, CAS 111-46-6) is a colorless, hygroscopic, water-miscible diol widely used in industry as a solvent, humectant, and antifreeze agent. Although chemically similar to glycerin in appearance and viscosity, DEG is highly toxic to humans. Following ingestion, DEG is metabolized to hydroxyethoxyacetaldehyde and 2-hydroxyethoxyacetic acid, producing central nervous system depression, severe metabolic acidosis, acute kidney injury with renal tubular necrosis, and hepatic damage. Documented lethal-dose estimates range from approximately 0.05 to 0.5 g/kg in children and roughly 1.0 to 1.6 g/kg in adults, making even low-level contamination a serious public health hazard.
Historically, DEG has entered the pharmaceutical and consumer product supply chain primarily through economically motivated adulteration or inadequate purification of glycerin and propylene glycol. Landmark tragedies include the 1937 sulfanilamide elixir incident in the United States, the 1996 pediatric syrup poisoning in Haiti, the 2006 cough syrup contamination in Panama, contaminated toothpaste incidents in 2007, and the acute kidney injury outbreaks in The Gambia, Uzbekistan, and other countries linked to contaminated medicinal syrups in 2022 and 2023. These events prompted strict global regulatory controls, including the USP Glycerin and Propylene Glycol monographs, USP General Chapter requirements for DEG and ethylene glycol (EG) limit testing, FDA guidance on glycerin testing, and WHO medical product alerts recommending DEG and EG screening across the entire excipient supply chain.
A comprehensive DEG residue monitoring and detection program combines risk-based raw material testing, validated chromatographic methods, traceable reference standards, and documented decision limits to ensure that every incoming lot of glycol-based excipients and every batch of oral liquid product meets pharmacopeial and internal safety specifications.
Testing Samples
Pharmaceutical Excipients and Raw Materials
Raw glycerin (glycerol), propylene glycol, polyethylene glycol (PEG) grades, sorbitol solution, and maltitol solution represent the highest-risk matrices because DEG can be introduced during crude glycerin refining or through deliberate substitution. Each incoming container or lot of these excipients should be sampled according to a statistically justified plan and tested for DEG and EG before release into production.
Oral Liquid and Syrup Preparations
Cough syrups, paracetamol and acetaminophen suspensions, antihistamine syrups, expectorants, vitamin drops, and pediatric liquid formulations frequently use glycerin or propylene glycol as vehicles, co-solvents, or sweetening agents. Finished product testing verifies that no DEG contamination occurred during manufacturing, storage, or transport, and provides critical safety data for vulnerable pediatric populations.
Cosmetic and Personal Care Products
Toothpaste, mouthwash, topical creams, lotions, deodorants, and humectant-containing cosmetics may incorporate glycerin derivatives at significant concentrations. Although primarily a dermal exposure route, ingestion risk from oral-care products and the reputational impact of contamination make DEG screening a standard requirement for global cosmetic brands and contract manufacturers.
Food-Grade Glycerin and Food Products
Food-grade glycerin (E422) is used as a humectant, sweetener, thickener, and solvent in beverages, confectionery, baked goods, and flavoring systems. DEG testing of food-grade glycerin lots supports compliance with food additive specifications and import inspection requirements in major jurisdictions.
Testing Items
A typical DEG residue monitoring protocol includes the following analytical items, reported on a weight-by-weight basis:
- DEG identification by retention time matching with a certified reference standard, supplemented by mass spectral confirmation where required.
- DEG quantitative assay, reported as percent weight-by-weight (percent w/w) or parts per million (ppm) against a calibration curve.
- Ethylene glycol (EG) co-determination, since EG shares the same contamination pathways and toxicological concerns as DEG.
- Related glycol screening, including triethylene glycol (TEG), to detect broader refining impurities or cross-contamination.
- Pharmacopeial limit evaluation against the standard acceptance criterion of not more than 0.1 percent w/w for DEG and for EG individually in glycerin and propylene glycol monographs.
- Optional low-level quantitation to internal action limits, commonly set at 0.05 percent w/w or lower, with GC-MS methods capable of achieving ppm-level limits of quantitation for heightened risk management.
Testing Methods
Gas chromatography with flame ionization detection (GC-FID) is the primary pharmacopeial technique for DEG and EG determination. Samples are typically diluted with an appropriate solvent such as methanol or water, filtered, and injected onto a capillary column with a polyethylene glycol (WAX-type) stationary phase using a temperature-programmed oven profile. Quantitation is performed by external standard calibration against certified DEG and EG reference materials, with system suitability verified through replicate standard injections, resolution checks between glycol peaks, and spike recovery experiments within the 80 to 120 percent acceptance range.
Gas chromatography coupled with mass spectrometry (GC-MS) provides confirmatory identification and substantially improved sensitivity. Electron ionization spectra and selected ion monitoring (SIM) acquisition enable unambiguous DEG confirmation in complex syrup matrices and achieve limits of quantitation in the low ppm range, supporting investigations, forensic analysis, and highly conservative internal release limits.
High-performance liquid chromatography (HPLC) with refractive index (RI) or evaporative light scattering detection (ELSD) offers an alternative for thermally sensitive or non-volatile matrices. Where syrup excipients interfere with direct analysis, sample preparation may include dilution optimization, filtration, or solid-phase extraction cleanup.
All methods are validated in accordance with ICH Q2(R2) and USP General Chapter requirements, covering specificity, linearity, range, accuracy, precision, limit of detection, limit of quantitation, and robustness. Method transfer between laboratories is documented through comparative studies, and stability-indicating capability is confirmed where DEG monitoring is integrated into stability programs.
Applications
DEG residue monitoring and detection programs serve multiple quality and regulatory functions across the product lifecycle:
- Incoming raw material release testing of every lot of glycerin, propylene glycol, and other glycol-based excipients prior to manufacturing use.
- Supplier qualification, periodic requalification, and supply chain risk surveillance, including audits supported by independent analytical verification.
- Finished product batch release testing for oral liquids, syrups, and suspensions intended for pediatric and adult populations.
- Market surveillance and post-marketing surveillance programs conducted by regulators, distributors, and brand owners.
- Import and export inspection support, including certificates of analysis for international shipments of glycerin and glycerin-containing products.
- Out-of-specification investigations, root cause analysis, and recall decision support following detection of suspect material.
- Long-term stability studies verifying that DEG levels remain controlled throughout product shelf life.
FAQ
Why is diethylene glycol testing mandatory for glycerin and propylene glycol?
DEG is a nephrotoxic and neurotoxic contaminant responsible for multiple mass-poisoning fatalities worldwide, almost always traced to adulterated or insufficiently purified glycerin. Because DEG resembles glycerin visually, only laboratory testing can detect it, so pharmacopeias and regulators require DEG and EG limit testing for every lot before use.
What is the regulatory limit for DEG residue?
The standard pharmacopeial acceptance criterion in the USP, Ph. Eur., and comparable monographs is not more than 0.1 percent w/w for DEG and not more than 0.1 percent w/w for ethylene glycol in glycerin and propylene glycol. WHO guidance treats any detected DEG in medicinal products as unacceptable, and many manufacturers apply stricter internal action limits at 0.05 percent or lower.
Which analytical method is used for DEG detection?
GC-FID is the standard screening and quantitation method specified in pharmacopeial monographs, while GC-MS is used for confirmatory identification and trace-level quantitation down to low ppm concentrations. HPLC with RI or ELSD detection is available as an alternative for specific matrices.
How frequently should DEG monitoring be performed?
Every incoming lot of glycerin, propylene glycol, or other glycol-based excipient should be tested before release, regardless of supplier history. Finished oral liquid products are tested per batch or per a justified periodic verification schedule, with increased frequency recommended during supplier changes or regional contamination alerts.
What sample quantity and turnaround time are typical for DEG testing?
Routine GC-FID screening generally requires 10 to 50 grams of sample and can be completed within 5 to 10 business days. Confirmatory GC-MS analysis and full validated-release testing may require additional time depending on sample preparation, matrix complexity, and reporting requirements.
Can DEG be detected at trace levels below the pharmacopeial limit?
Yes. Validated GC-MS methods achieve limits of quantitation in the range of approximately 10 to 50 ppm, enabling early detection of contamination trends well before levels approach the 0.1 percent pharmacopeial limit and supporting proactive supply chain interventions.